| 01:23 PM |
Incorporation Of A Subsidiary Company
|
| 10:47 PM |
Completion And Results Of Postal Ballot Dated 17 March 2026
|
| 04:09 PM |
Rumour verification - Regulation 30(11)
|
| 11:28 AM |
Clarification sought from Sun Pharmaceutical Industries Ltd
|
| 03:55 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 03:50 PM |
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
|
| 04:54 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 03:57 PM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 12:27 AM |
Updates On Fibromun And Nidlegy
|
| 09:11 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 08:34 PM |
Closure of Trading Window
|
| 08:35 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 04:13 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:32 PM |
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
|
| 10:38 AM |
Shareholder Satisfaction Survey On RTA Services
|
| 04:23 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 03:45 PM |
Announcement under Regulation 30 (LODR)-Investor Presentation
|
| 05:38 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 07:48 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 06:28 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 07:05 PM |
Sustainability Report For The Financial Year 2024-25
|
| 01:31 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 08:21 PM |
Q3FY26 Earnings Call Audio Recording
|
| 05:39 PM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 02:30 PM |
Corporate Action-Board approves Dividend
|
| 02:26 PM |
Unaudited Financial Results For The Quarter And Nine Months Ended 31 December 2025
|
| 08:21 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 04:52 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 06:59 PM |
Intimation Of The Record Date For The Purpose Of The Interim Dividend For FY 2025-26 Is 05 February 2026
|
| 06:48 PM |
Board Meeting Intimation for Approval Of Financial Results For The Quarter And Nine Months Ended 31 December 2025 And The Interim Dividend For FY 2025-26
|
| 12:46 PM |
Rumour verification - Regulation 30(11)
|
| 10:55 AM |
Clarification sought from Sun Pharmaceutical Industries Ltd
|
| 10:52 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 02:41 PM |
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
|
| 07:46 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 04:37 PM |
Closure of Trading Window
|
| 02:51 PM |
Announcement under Regulation 30 (LODR)-Investor Presentation
|
| 01:10 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 08:25 AM |
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - US FDA Determines Baska Facility Inspection Classification As OAI
|
| 11:08 PM |
Intimation Under Regulation 30 - Approval Of Proposal For Greenfield Project
|
| 09:11 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 10:29 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 04:05 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 04:04 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 08:58 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 04:00 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 05:04 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 07:47 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 12:01 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 08:30 PM |
Investor Call Audio Recording
|
| 04:21 PM |
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
|
| 04:05 PM |
Financial Results For The Quarter And Half-Year Ended 30 September 2025
|
| 02:25 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 05:51 PM |
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30 September 2025.
|
| 04:48 PM |
ESG Overview For FY 2024-25
|
| 08:23 PM |
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
|
| 02:39 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 06:01 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 04:46 PM |
Closure of Trading Window
|
| 04:25 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 11:40 AM |
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
|
| 08:26 PM |
Update On US FDA Inspection At Sun Pharma Halol Facility
|
| 05:28 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 05:34 PM |
Announcement under Regulation 30 (LODR)-Investor Presentation
|
| 06:38 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 03:19 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 04:55 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 02:47 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 10:20 AM |
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
|
| 06:58 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 04:35 PM |
Rumour verification - Regulation 30(11)
|
| 01:28 PM |
Clarification sought from Sun Pharmaceutical Industries Ltd
|
| 02:35 PM |
Financial Results For The Quarter Ended 30 June 2025
|
| 02:31 PM |
Board Meeting Outcome for Outcome Of The Board Meeting
|
| 04:47 PM |
Execution Of Settlement Agreement In The In Re Generic Pharmaceuticals Pricing Antitrust Litigation
|
| 08:25 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 02:04 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:14 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 04:36 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:48 PM |
Announcement under Regulation 30 (LODR)-Investor Presentation
|
| 05:59 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 04:45 PM |
Sun Pharma Announces Launch Of LEQSELVI??? In The US
|
| 04:26 PM |
Sun Pharma Announces Settlement On LEQSELVI???
|
| 05:34 PM |
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Q1 Of FY 2025-26
|
| 04:39 PM |
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
|
| 07:27 PM |
Business Responsibility and Sustainability Reporting (BRSR)
|
| 05:56 PM |
Notice For 33Rd Annual General Meeting Of Sun Pharmaceutical Industries Limited
|
| 05:50 PM |
Reg. 34 (1) Annual Report.
|
| 12:57 AM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 11:50 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 02:29 AM |
Update On US FDA Halol Inspection
|
| 06:00 PM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 03:30 PM |
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
|
| 05:14 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 07:49 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 06:38 PM |
Compliances-Reg.24(A)-Annual Secretarial Compliance
|
| 05:33 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 05:22 PM |
Announcement under Regulation 30 (LODR)-Updates on Acquisition
|
| 08:57 PM |
Investor Audio Call Recording
|
| 05:29 PM |
Intimation Of Record Date For The Purpose Of Final Dividend
|
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback